The Role of Placental Protein 14 in the Pathogenesis of Endometriosis

Placental protein 14 (PP-14) is the principal secretory phase product of endometrium and has been shown to inhibit cell immune function. But its role in the pathogenesis of endometriosis is controversy. The objective of this study is to determine the concentrations of PP-14 in peritoneal fluid (PF) and serum and PP-14 protein expression in endometriotic lesions in women with ovarian endometriosis (n = 75) when compared to women without endometriosis (n = 49) between day 7 and day 20 of their menstrual cycle. Concentrations of PP-14 in PF and serum as well as PP-14 protein expression in endometriotic lesions in women with and without endometriosis were evaluated by using enzyme-linked immunosorbent assay and immunohistochemical staining, respectively. Serum PP-14 concentrations were significantly increased in women with endometriosis (7.5 ± 1.4 ng/mL) compared to those in women without endometriosis (5.8 ± 0.9 ng/mL; P < .05) and statistically decreased after surgery and further reduced by using gonadotropin-releasing hormone agonist therapy (P .05). In women with endometriosis, scores of PP-14 protein expression in the lesions (n = 50, 2.2 [0∼5.8]) were significantly correlated with serum PP-14 concentrations (n = 50, 7.6 ± 1.3 ng/mL; P < .01). Our results suggest that PP-14 may play an important role in the pathogenesis of endometriosis. Similar content being viewed by others

Portelli M, Pollacco J, Sacco K, Schembri-Wismayer P, Calleja-Agius J. Endometrial seedlings. A survival instinct? Immunomodulation and its role in the pathophysiology of endometriosis. Minerva Ginecol. 2011;63(6):563–570. Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 2007;12(3):194–202. Siristatidis C, Nissotakis C, Chrelias C, Iacovidou H, Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res. 2006;32(2): 162–170. Pockley AG, Bolton AE. Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes. Clin Exp Immunol. 1989;77(2):252–256. Bersinger NA, Birkhäuser MH, Yared M, Wunder DM. Serum glycodelin pattern during the menstrual cycle in healthy young women. Acta Obstet Gynecol Scand. 2009;88(11):1215–1221. Rachmilewitz J, Riely GJ, Tykocinski ML. Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol. 1999; 191(1):26–33. Mukhopadhyay D, Sundereshan S, Rao C, Karande AA. Placental protein 14 induces apoptosis in T cells but not in monocytes. J Biol Chem. 2001;276(30):28268–28273. Bersinger NA, von Roten S, Wunder DM, Raio L, Dreher E, Mueller MD. PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. Am J Obstet Gynecol. 2006; 195(1):103–108. Drosdzol-Cop A, Skrzypulec-Plinta V. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res. 2012;38(10):1245–1253. Koninckx PR, Riittinen L, Seppala M, Cornillie FJ. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis. Fertil Steril. 1992;57(3):523–530. Telimaa S, Kauppila A, Rönnberg L, Suikkari AM, Seppälä M. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate. Am J Obstet Gynecol. 1989;161(4):866–871. Vodolazkaia A, El-Aalamat Y, Popovic D, et al. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod. 2012;27(9):2698–2711. Cornillie FJ, Lauweryns JM, Seppälä M, Riittinen L, Koninckx PR. Expression of endometrial protein PP14 in pelvic and ovarian endometriotic implants. Hum Reprod. 1991;6(10):1411–1415. Meola J, Dentillo DB, Rosa e Silva JC, et al. Glycodelin expression in the endometrium of healthy women and in the eutopic and ectopic endometrium of women with endometriosis. Fertil Steril. 2009;91(5):1676–1680. Ramos IM, Podgaec S, Abrão MS, Rd Oliveira, Baracat EC. Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: acase-control study. Rev Assoc Med Bras. 2012;58(1):26–32. Barbosa CP, Souza AM, Bianco B, Christofolini D, Bach FA, Lima GR. Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values. Sao Paulo Med J. 2009;127(6):342–345. Tokmak A, Ugur M, Tonguc E, Var T, Moraloğlu O, Ozaksit G. The value of urocortin and Ca-125 in the diagnosis of endometrioma. Arch Gynecol Obstet. 2011;283(5):1075–1079. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril. 1997;67(5):817–821. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–25. Zhang X, Qi C, Lin J. Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding. Fertil Steril. 2010;93(7):2362–2367. Zhang X, Yao H, Huang X, Lu B, Xu H, Zhou C. Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis. Hum Reprod. 2010;25(2):392–397. Fan R, Qiu L, Huang X, et al. Increased nerve fibers in placental bed myometrium in women with preeclampsia. Reprod Sci. 2011; 18(12):1262–1266. Huang X, Chen L, Fu G, Xu H, Zhang X. Decreased expression of pigment epithelium-derived factor and increased microvascular density in ovarian endometriotic lesions in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2012;165(1): 104–109. Okamoto N, Uchida A, Takakura K, et al. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol. 1991;26(4):137–142. Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J. Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J Immunol. 2004; 173(9):5524–5530. Esfandiari N, Ai J, Nazemian Z, Javed MH, Gotlieb L, Casper RF. Expression of glycodelin and cyclooxygenase-2 in human endometrial tissue following three-dimensional culture. Am J Reprod Immunol. 2007;57(1):49–54. Julkunen M, Apter D, Seppälä M, Stenman UH, Bohn H. Serum levels of placental protein 14 reflect ovulation in nonconceptional menstrual cycles. Fertil Steril. 1986;45(1):47–50. Westergaard LG, Wiberg N, Andersen CY, et al. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. Hum Reprod. 1998;13(9):2612–2619. Wei Q, St Clair JB, Fu T, Stratton P, Nieman LK. Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril. 2009;91(5): 1686–1691. Afshar Y, Hastings J, Roqueiro D, Jeong JW, Giudice LC, Fazleabas AT. Changes in eutopic endometrial gene expression during the progression of experimental endometriosis in the baboon, papio anubis. Biol Reprod. 2013;88(2):44. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Wang, P., Zhu, L. & Zhang, X. The Role of Placental Protein 14 in the Pathogenesis of Endometriosis. Reprod. Sci. 20, 1465–1470 (2013). https://doi.org/10.1177/1933719113488452 Published: Issue date: DOI: https://doi.org/10.1177/1933719113488452